InvestorsHub Logo
Followers 20
Posts 7168
Boards Moderated 0
Alias Born 03/02/2013

Re: None

Thursday, 12/21/2017 5:08:24 PM

Thursday, December 21, 2017 5:08:24 PM

Post# of 1715

Fahad Mohammed Al Tamimi, a Senior Officer and Director, acquired 4,470,763 Common Shares on a direct ownership basis at a price of $0.300 through a prospectus or prospectus exempt offering on December 14th, 2017. This represents a $1,341,229 investment into the company's shares and an account share holdings change of 43.6%.



https://m.canadianinsider.com/private-eye/2017-12-18/officer-buying-kerr-mines-ker

Prominent business leader Fahad Al Tamimi is organising a significant dinner event next week in London and the theme of the evening has just been announced: ‘Reactivating a Patient’s Immune System to Eradicate Cancer’. The occasion will help support further research in the area of radiation therapy.

Fahad Al Tamimi will be joined by a selection of notable guests who will have the opportunity to meet one of the world’s leading researchers in this space. Dr James Welsh, who is currently based at the University of Texas in America, will share his views on the latest developments in this essential field of medical study.

Dr Welsh will provide fascinating insights and share his views on the latest findings in this crucial area of healthcare. The discussion will offer an overview but also provide more specific detail regarding strategies for combining immunotherapy with radiation for anticancer therapy.


http://www.fahadaltamimi.com/news/

I look forward to going to one of these dinners and donating when these Kerr Mine shares POP... in 2019...?